Sera Prognostics

About:

Sera Prognostics develops blood tests that are predictive of preterm birth, preeclampsia, and other pregnancy complications.

Website: http://www.seraprognostics.com

Top Investors: LabCorp, Elevance Health, Vivo Capital, OUP (Osage University Partners), InterWest Partners

Description:

Sera is a women’s health diagnostics company dedicated to improving the lives of women and babies through precision pregnancy care. Sera provides pivotal information during pregnancy to physicians, designed to help improve the health of their patients, and to reduce the costs of healthcare delivery. Sera has a robust pipeline of innovative diagnostic tests focused on the prediction of preterm birth risk and other complications of pregnancy. Sera’s PreTRM® Test reports to a physician the individualized risk of spontaneous premature delivery in a pregnancy, enabling earlier proactive interventions in women with higher risk.